866-997-4948(US-Canada Toll Free)

Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2022

Published By :

QYResearch

Published Date : Apr 2017

Category :

Therapeutic Area

No. of Pages : 90 Pages

This report studies the global Glioblastoma Multiforme Treatment market, analyzes and researches the Glioblastoma Multiforme Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
AbbVie, Inc
Activartis GmbH
Agenus Inc
Arog Pharmaceuticals, Inc
Bristol-Myers Squibb Company
Cavion LLC
Celldex Therapeutics Inc
Cortice Biosciences
Exelixis Inc
F. Hoffmann-La Roche Ltd

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Glioblastoma Multiforme Treatment can be split into
Bevacizumab (Avastin)
Temozolomide (Temodar and Temodal and Temcad)
Carmustine (BiCNU)

Market segment by Application, Glioblastoma Multiforme Treatment can be split into
Hospital
Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2022
1 Industry Overview of Glioblastoma Multiforme Treatment
1.1 Glioblastoma Multiforme Treatment Market Overview
1.1.1 Glioblastoma Multiforme Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Glioblastoma Multiforme Treatment Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Glioblastoma Multiforme Treatment Market by Type
1.3.1 Bevacizumab (Avastin)
1.3.2 Temozolomide (Temodar and Temodal and Temcad)
1.3.3 Carmustine (BiCNU)
1.4 Glioblastoma Multiforme Treatment Market by End Users/Application
1.4.1 Hospital
1.4.2 Clinic

2 Global Glioblastoma Multiforme Treatment Competition Analysis by Players
2.1 Glioblastoma Multiforme Treatment Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 AbbVie, Inc
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Glioblastoma Multiforme Treatment Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Activartis GmbH
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Glioblastoma Multiforme Treatment Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Agenus Inc
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Glioblastoma Multiforme Treatment Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Arog Pharmaceuticals, Inc
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Glioblastoma Multiforme Treatment Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Bristol-Myers Squibb Company
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Glioblastoma Multiforme Treatment Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Cavion LLC
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Glioblastoma Multiforme Treatment Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Celldex Therapeutics Inc
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Glioblastoma Multiforme Treatment Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Cortice Biosciences
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Glioblastoma Multiforme Treatment Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Exelixis Inc
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Glioblastoma Multiforme Treatment Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 F. Hoffmann-La Roche Ltd
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Glioblastoma Multiforme Treatment Revenue (Value) (2012-2017)
3.10.5 Recent Developments

4 Global Glioblastoma Multiforme Treatment Market Size by Type and Application (2012-2017)
4.1 Global Glioblastoma Multiforme Treatment Market Size by Type (2012-2017)
4.2 Global Glioblastoma Multiforme Treatment Market Size by Application (2012-2017)
4.3 Potential Application of Glioblastoma Multiforme Treatment in Future
4.4 Top Consumer/End Users of Glioblastoma Multiforme Treatment

5 United States Glioblastoma Multiforme Treatment Development Status and Outlook
5.1 United States Glioblastoma Multiforme Treatment Market Size (2012-2017)
5.2 United States Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2016 and 2017)

6 EU Glioblastoma Multiforme Treatment Development Status and Outlook
6.1 EU Glioblastoma Multiforme Treatment Market Size (2012-2017)
6.2 EU Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2016 and 2017)

7 Japan Glioblastoma Multiforme Treatment Development Status and Outlook
7.1 Japan Glioblastoma Multiforme Treatment Market Size (2012-2017)
7.2 Japan Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2016 and 2017)

8 China Glioblastoma Multiforme Treatment Development Status and Outlook
8.1 China Glioblastoma Multiforme Treatment Market Size (2012-2017)
8.2 China Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2016 and 2017)

9 India Glioblastoma Multiforme Treatment Development Status and Outlook
9.1 India Glioblastoma Multiforme Treatment Market Size (2012-2017)
9.2 India Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Glioblastoma Multiforme Treatment Development Status and Outlook
10.1 Southeast Asia Glioblastoma Multiforme Treatment Market Size (2012-2017)
10.2 Southeast Asia Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Glioblastoma Multiforme Treatment Market Size (Value) by Regions (2017-2022)
11.1.1 United States Glioblastoma Multiforme Treatment Revenue and Growth Rate (2017-2022)
11.1.2 EU Glioblastoma Multiforme Treatment Revenue and Growth Rate (2017-2022)
11.1.3 Japan Glioblastoma Multiforme Treatment Revenue and Growth Rate (2017-2022)
11.1.4 China Glioblastoma Multiforme Treatment Revenue and Growth Rate (2017-2022)
11.1.5 India Glioblastoma Multiforme Treatment Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Glioblastoma Multiforme Treatment Revenue and Growth Rate (2017-2022)
11.2 Global Glioblastoma Multiforme Treatment Market Size (Value) by Type (2017-2022)
11.3 Global Glioblastoma Multiforme Treatment Market Size by Application (2017-2022)

12 Glioblastoma Multiforme Treatment Market Dynamics
12.1 Glioblastoma Multiforme Treatment Market Opportunities
12.2 Glioblastoma Multiforme Treatment Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Glioblastoma Multiforme Treatment Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Glioblastoma Multiforme Treatment Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Glioblastoma Multiforme Treatment Product Scope
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) (2012-2017)
Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Glioblastoma Multiforme Treatment Market Share by Regions in 2016
Figure United States Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Glioblastoma Multiforme Treatment Market Share by Type in 2016
Figure Bevacizumab (Avastin) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Temozolomide (Temodar and Temodal and Temcad) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Carmustine (BiCNU) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Glioblastoma Multiforme Treatment Market Share by Application in 2016
Figure Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate in Hospital (2012-2017)
Figure Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate in Clinic (2012-2017)
Figure Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate in Applications 3 (2012-2017)
Table Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2016 and 2017)
Figure Glioblastoma Multiforme Treatment Market Size Share by Players in 2016
Figure Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Table AbbVie, Inc Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of AbbVie, Inc (2012-2017)
Figure AbbVie, Inc Glioblastoma Multiforme Treatment Business Revenue Market Share in 2016
Table Activartis GmbH Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Activartis GmbH (2012-2017)
Figure Activartis GmbH Glioblastoma Multiforme Treatment Business Revenue Market Share in 2016
Table Agenus Inc Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Agenus Inc (2012-2017)
Figure Agenus Inc Glioblastoma Multiforme Treatment Business Revenue Market Share in 2016
Table Arog Pharmaceuticals, Inc Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Arog Pharmaceuticals, Inc (2012-2017)
Figure Arog Pharmaceuticals, Inc Glioblastoma Multiforme Treatment Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Company Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Bristol-Myers Squibb Company (2012-2017)
Figure Bristol-Myers Squibb Company Glioblastoma Multiforme Treatment Business Revenue Market Share in 2016
Table Cavion LLC Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Cavion LLC (2012-2017)
Figure Cavion LLC Glioblastoma Multiforme Treatment Business Revenue Market Share in 2016
Table Celldex Therapeutics Inc Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Celldex Therapeutics Inc (2012-2017)
Figure Celldex Therapeutics Inc Glioblastoma Multiforme Treatment Business Revenue Market Share in 2016
Table Cortice Biosciences Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Cortice Biosciences (2012-2017)
Figure Cortice Biosciences Glioblastoma Multiforme Treatment Business Revenue Market Share in 2016
Table Exelixis Inc Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Exelixis Inc (2012-2017)
Figure Exelixis Inc Glioblastoma Multiforme Treatment Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Ltd Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of F. Hoffmann-La Roche Ltd (2012-2017)
Figure F. Hoffmann-La Roche Ltd Glioblastoma Multiforme Treatment Business Revenue Market Share in 2016
Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Type (2012-2017)
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2012
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2013
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2014
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2015
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2016
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2017
Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application (2012-2017)
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2012
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2013
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2014
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2015
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2016
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Glioblastoma Multiforme Treatment
Figure United States Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2012-2017)
Figure United States Glioblastoma Multiforme Treatment Market Size Share by Players in 2016
Figure United States Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Figure EU Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2012-2017)
Figure EU Glioblastoma Multiforme Treatment Market Size Share by Players in 2016
Figure EU Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Figure Japan Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2012-2017)
Figure Japan Glioblastoma Multiforme Treatment Market Size Share by Players in 2016
Figure Japan Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Figure China Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2012-2017)
Figure China Glioblastoma Multiforme Treatment Market Size Share by Players in 2016
Figure China Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Figure India Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2012-2017)
Figure India Glioblastoma Multiforme Treatment Market Size Share by Players in 2016
Figure India Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Share by Players in 2016
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Regions (2017-2022)
Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Regions (2017-2022)
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions in 2017
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions in 2022
Figure United States Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Type (2017-2022)
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2017
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2022
Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application (2017-2022)
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2017
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2022

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *